Nanotechnology has long been used in the pharmaceutical industry to improve bioavailability and ensure consistent dosing. Cannabinoids, as hydrophobic compounds, struggle with water solubility, causing instability and separation that lead to dosing and bioavailability challenges.
PhD high-pressure homogenizers equip formulators with the high-energy tools needed to create stable and bioavailable cannabinoid nanoparticles for both R&D and production. These formulations enhance stability, improve efficacy, and ensure consistent, reliable cannabinoid products for consumers and the industry alike.